IDH-MUTANT GRADE 2 OR 3 ASTROCYTOMA

Clinical trials for IDH-MUTANT GRADE 2 OR 3 ASTROCYTOMA explained in plain language.

Never miss a new study

Get alerted when new IDH-MUTANT GRADE 2 OR 3 ASTROCYTOMA trials appear

Sign up with your email to follow new studies for IDH-MUTANT GRADE 2 OR 3 ASTROCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill aims to extend remission for young adults with brain cancer

Disease control Recruiting now

This study is testing if taking a daily pill called vorasidenib can help keep a specific type of brain tumor (IDH-mutant astrocytoma) from growing or coming back after patients finish their initial chemotherapy and radiation. It will involve about 468 adults who have completed th…

Matched conditions: IDH-MUTANT GRADE 2 OR 3 ASTROCYTOMA

Phase: PHASE3 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

IDH-MUTANT GRADE 2 OR 3 ASTROCYTOMA

Get alerted when new IDH-MUTANT GRADE 2 OR 3 ASTROCYTOMA trials appear

New pill aims to extend remission for young adults with brain cancer